中證監要求珠海萬達就港上市計劃補充材料
大連萬達集團擬分拆珠海萬達商管在港上市,中證監於本月2日要求集團提供7項補充材料,就公司內控、關聯交易、募集資金使用等方面問題進行說明。
當中包括要求珠海萬達補充說明公司治理及內部控制運行情況,內部控制制度是否健全有效,是否存在被控股股東或其他關聯方資金佔用的情形,是否存在對外擔保及為控股股東提供擔保的情形。以及說明相關防止關聯方資金佔用和避免為控股股東提供擔保的內控制度和保障措施。另外,亦需說明報告期內公司與控股股東及其他關聯方之間的關聯交易和資金往來,該等關聯交易佔公司報告期內營業收入或營業成本的比重,以及業務的獨立性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.